Lenvatinib(CAS417716-92-8)

Min.Order / FOB Price:Get Latest Price

10 Gram	Negotiable

10 Gram

Negotiable

Min.Order :10 Gram
Purity: 99%
Payment Terms : L/C,T/T,

Keywords

Lenvatinib Lenvatinib manufacturer High-quality E7080

Quick Details

Appearance:white powder
Application:E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively.
PackAge:As customer request
ProductionCapacity:100|Kilogram|Week
Storage:
Transportation:By Sea/Air/Courier

Superiority:

Triumph Chemical Title

Triumph Company Office picture

Triumph Company advantage

Triumph Testing title picture

Triumph Testing way

Welcome to contact us

Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details:

Lenvatinib

CAS:	417716-92-8
MF:	C21H19ClN4O4
MW:	426.85
Appearance:	White powder
Assay:	99%
Boiling point:	627.2±55.0 °C(Predicted)
desnity:	1.46
Uses:	Lenvatinib is a thyroid cancer drug. E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively.

View All

Visit Store